Key facts
- This page summarizes Alex Andre's Form 4 filing for Algorhythm Holdings, Inc. (RIME).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Feb 2025, 17:01.
Alex Andre - 13 Feb 2025 Form 4 Insider Report for Algorhythm Holdings, Inc. (RIME)
- Reporting relationship
- CFO & General Counsel
- Issuer ticker
- RIME
- Reported as of
- 13 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Feb 2025, 17:01:16 UTC
- Next SEC filing
- 25 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Alex Andre
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Alex Andre filed Form 4 for Algorhythm Holdings, Inc. (RIME) on 18 Feb 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RIME
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +23,818
- Change %
- Price
- $0.000000
- Shares after
- 23,818
- Date
- 13 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RIME
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +23,818
- Change %
- Price
- $0.000000
- Shares after
- 23,818
- Date
- 13 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,818
- Exercise price
- $2.78
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The reported transaction involved the Reporting Person's receipt of a restricted stock award for 23,818 shares of the Issuer's common stock. The restricted stock award was granted by the Board of Directors of the Issuer as an inducement grant pursuant to the Nasdaq Listing Rule 5635(c)(4). Twenty-five percent (25%) of the total number of shares subject to the restricted stock award shall vest on the first anniversary of the grant date and six and one-quarter percent (6.25%) of the remaining shares shall vest each quarter thereafter.
Footnote F2
The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 23,818 shares of the Issuer's common stock. The non-qualified stock option was granted by the Board of Directors of the Issuer as an inducement grant pursuant to the Nasdaq Listing Rule 5635(c)(4).
Footnote F3
Twenty-five percent (25%) of the total number of shares subject to the non-qualified stock option shall vest and become exercisable on the first anniversary of the grant date and six and one-quarter percent (6.25%) of the remaining shares shall vest and become exercisable each quarter thereafter.